ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Black Tea Is Great for Your Gut

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

 
Print Page
Email Article

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006 – Source: Journal of Internal Medicine, Dec 2010

  [ 10 votes ]   [ Discuss This Article ]
By Mary E Holmqvist, et al. • www.ProHealth.com • December 9, 2010


Background: The risk of ischemic heart disease (IHD) [reduced blood flow/oxygen supply to the heart muscle], and in particular myocardial infarction (MI) [“heart attack”], is increased amongst patients with established rheumatoid arthritis (RA). Few studies have included contemporary patients with RA.

• We recently reported that the risk of IHD is not elevated before the onset of RA symptoms.

• However, when, in relation to RA diagnosis, the risk is increased is unknown.

Objective: To assess the risk of MI and other IHD events amongst patients diagnosed with RA during the last decade and within 18 months following RA symptom onset, compared to the general population, by time since RA diagnosis, year of RA diagnosis and by rheumatoid factor (RF) status.

Methods and patients: A Swedish inception cohort of RA (number = 7,469) diagnosed between 1995 and 2006 and a matched general population comparator cohort (number = 37,024), was identified and linked to national registers of morbidity and mortality from IHD. Relative risks (RRs) of MI and other IHD events were estimated using Cox regression.

Results:

During follow-up, 233 patients with RA and 701 controls developed a first MI, corresponding to an overall RR of MI of 1.6 (95% confidence interval 1.4, 1.9). Note: a risk ratio of 1.0 would indicate no difference in average risk. [Note: The RR of 1.6 indicates average risk in these RA patients was increased by 60%.]

Increased risks of MI were already detected within 1 to 4 years following RA diagnosis, as well as in:

• Patients diagnosed with RA during the last 5 years,

• In RF-negative patients [Note: RF (rheumatoid factor) is an antibody considered an indicator of RA not normally found in healthy people. It escalates so that it is detected via blood tests in 33% of patients at 3 months after diagnosis and in 75% at one year. As many as 20% of RA patients remain RF negative.]

• And for transmural as well as nontransmural MIs [a transmural MI affects the full thickness of the heart wall].

Conclusions:

MI risk increases rapidly following RA diagnosis, suggesting the importance of additional mechanisms other than atherosclerosis [plaque buildup in artery walls].

The elevated short-term risk is present amongst patients diagnosed in recent years, underscoring the importance of MI prevention from the time of RA diagnosis.

Source: Journal of Internal Medicine, Dec 2010;268: 578–585. Holmqvist ME, Wedren S, Jacobsson LTH, Klareskog L, Nyberg F, Rantapa-Dahlzvist S, Alfresson L, Askling J. Institute of Environmental Medicine, Karolinska Institutet, Stockholm; Karolinska Institutet/Karolinska Hospital, Stockholm; Malmö University Hospital, Malmö; AstraZeneca R&D, Mölndal; and Umea University Hospital, Umea, Sweden. [Email: marie.holmqvist@ki.se]





Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Energy NADH™ 12.5mg Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Priming Your Immune System for Cold & Flu Season Priming Your Immune System for Cold & Flu Season
Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol
The Big Blue Fish that Helps Chase the Blues Away The Big Blue Fish that Helps Chase the Blues Away
When a Good Night's Sleep Is Just a Daydream... When a Good Night's Sleep Is Just a Daydream...

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map